Diabetology & Metabolic Diseases

It is a well-known fact that overweight (having a BMI of 30 or above) are at greater risk of developing metabolic chronic disorders like type 2 diabetes mellitus, insulin resistance. Accumulation of adipose tissue affects metabolism by secreting hormones, glycerol, and other substances including leptin, cytokines, adiponectin, and proinflammatory substances, and non-esterified fatty acids which are involved in the development of insulin resistance and disruption of fat metabolism. And the secretion of these substances will be increased leading to diabetes in obese individuals

 

  • Bariatric surgery
  • Malabsorption
  • Cardiovascular risk factors

Related Conference of Diabetology & Metabolic Diseases

January 18-19, 2021

Global summit on Obesity, Diet and Nutrition

London, Aland Islands
January 22-23, 2021

6th Annual Meet on Obesity and Diet

Vienna, Austria
April 06-07, 2021

21st World Congress on Obesity and Metabolic Diseases

Manila, Philippines
July 05-06, 2021

17th Euro Obesity and Endocrinology Congress

Valencia, Spain

Diabetology & Metabolic Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in